The TB Drug Accelerator (TBDA)
The TB Drug Accelerator (TBDA) is a collaboration of academic and industry partners that aims to speed up the discovery and development of novel preclinical drug candidates against TB by working together on early-stage pre-clinical research.
IMI ERA4TB
ERA4TB plans to study new molecular entities in combination with one another and will focus on preclinical/first-in-human trials. The main objective of ERA4TB is to create a European open platform to accelerate the development of new regimens for the treatment of tuberculosis.
IMI UNITE4TB
UNITE4TB follows an overarching racetrack concept to deliver an efficient, global clinical trials network equipped to implement phase 2 trials that conform to the highest regulatory standards.
